JP2019189560A - Tablet - Google Patents
Tablet Download PDFInfo
- Publication number
- JP2019189560A JP2019189560A JP2018084436A JP2018084436A JP2019189560A JP 2019189560 A JP2019189560 A JP 2019189560A JP 2018084436 A JP2018084436 A JP 2018084436A JP 2018084436 A JP2018084436 A JP 2018084436A JP 2019189560 A JP2019189560 A JP 2019189560A
- Authority
- JP
- Japan
- Prior art keywords
- line
- tableting
- tablet
- sodium bicarbonate
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 claims abstract description 37
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 33
- 238000010521 absorption reaction Methods 0.000 claims abstract description 33
- 229920000642 polymer Polymers 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 19
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 16
- 150000007524 organic acids Chemical class 0.000 claims abstract description 13
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims abstract description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 124
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 63
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 61
- 230000005484 gravity Effects 0.000 claims description 21
- 239000001913 cellulose Substances 0.000 claims description 14
- 229920002678 cellulose Polymers 0.000 claims description 14
- 239000013078 crystal Substances 0.000 claims description 14
- 229940057995 liquid paraffin Drugs 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 8
- 230000007613 environmental effect Effects 0.000 claims description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 18
- 238000009472 formulation Methods 0.000 abstract description 12
- 239000001569 carbon dioxide Substances 0.000 abstract description 9
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 9
- 239000002253 acid Substances 0.000 abstract description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract description 3
- 239000003826 tablet Substances 0.000 description 65
- 238000012360 testing method Methods 0.000 description 40
- 239000011800 void material Substances 0.000 description 27
- -1 trimethylammonio Chemical group 0.000 description 25
- 230000000052 comparative effect Effects 0.000 description 20
- 238000000034 method Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000003287 bathing Methods 0.000 description 14
- 235000010980 cellulose Nutrition 0.000 description 13
- 235000002639 sodium chloride Nutrition 0.000 description 13
- 238000007906 compression Methods 0.000 description 12
- 230000006835 compression Effects 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000000284 extract Substances 0.000 description 10
- 238000004364 calculation method Methods 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 239000013040 bath agent Substances 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 5
- 239000012459 cleaning agent Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 229940060184 oil ingredients Drugs 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229920002907 Guar gum Polymers 0.000 description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 235000006886 Zingiber officinale Nutrition 0.000 description 4
- 244000273928 Zingiber officinale Species 0.000 description 4
- 235000008397 ginger Nutrition 0.000 description 4
- 235000010417 guar gum Nutrition 0.000 description 4
- 239000000665 guar gum Substances 0.000 description 4
- 229960002154 guar gum Drugs 0.000 description 4
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 240000003538 Chamaemelum nobile Species 0.000 description 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- 241000218657 Picea Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 241000206608 Pyropia tenera Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003905 agrochemical Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000007891 compressed tablet Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000007542 hardness measurement Methods 0.000 description 3
- 238000010191 image analysis Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 235000009421 Myristica fragrans Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 235000008632 Santalum album Nutrition 0.000 description 2
- 240000000513 Santalum album Species 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229920006322 acrylamide copolymer Polymers 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UENOQWSWMYJKIW-UHFFFAOYSA-N 1,2,2-trimethylcyclohexan-1-ol Chemical compound CC1(C)CCCCC1(C)O UENOQWSWMYJKIW-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- CUVLMZNMSPJDON-UHFFFAOYSA-N 1-(1-butoxypropan-2-yloxy)propan-2-ol Chemical compound CCCCOCC(C)OCC(C)O CUVLMZNMSPJDON-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- ASLICXGLMBICCD-UHFFFAOYSA-N 1-ethyl-4,5-dihydroimidazole Chemical compound CCN1CCN=C1 ASLICXGLMBICCD-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- GQCZPFJGIXHZMB-UHFFFAOYSA-N 1-tert-Butoxy-2-propanol Chemical compound CC(O)COC(C)(C)C GQCZPFJGIXHZMB-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- ZUAURMBNZUCEAF-UHFFFAOYSA-N 2-(2-phenoxyethoxy)ethanol Chemical compound OCCOCCOC1=CC=CC=C1 ZUAURMBNZUCEAF-UHFFFAOYSA-N 0.000 description 1
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- COBPKKZHLDDMTB-UHFFFAOYSA-N 2-[2-(2-butoxyethoxy)ethoxy]ethanol Chemical compound CCCCOCCOCCOCCO COBPKKZHLDDMTB-UHFFFAOYSA-N 0.000 description 1
- JDSQBDGCMUXRBM-UHFFFAOYSA-N 2-[2-(2-butoxypropoxy)propoxy]propan-1-ol Chemical compound CCCCOC(C)COC(C)COC(C)CO JDSQBDGCMUXRBM-UHFFFAOYSA-N 0.000 description 1
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 1
- YJTIFIMHZHDNQZ-UHFFFAOYSA-N 2-[2-(2-methylpropoxy)ethoxy]ethanol Chemical compound CC(C)COCCOCCO YJTIFIMHZHDNQZ-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- VATRWWPJWVCZTA-UHFFFAOYSA-N 3-oxo-n-[2-(trifluoromethyl)phenyl]butanamide Chemical compound CC(=O)CC(=O)NC1=CC=CC=C1C(F)(F)F VATRWWPJWVCZTA-UHFFFAOYSA-N 0.000 description 1
- LDMRLRNXHLPZJN-UHFFFAOYSA-N 3-propoxypropan-1-ol Chemical compound CCCOCCCO LDMRLRNXHLPZJN-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- MUDSDYNRBDKLGK-UHFFFAOYSA-N 4-methylquinoline Chemical compound C1=CC=C2C(C)=CC=NC2=C1 MUDSDYNRBDKLGK-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- VNFYMAPAENTMMO-UHFFFAOYSA-N 5-chloro-2-methylquinoline Chemical compound ClC1=CC=CC2=NC(C)=CC=C21 VNFYMAPAENTMMO-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 240000006054 Agastache cana Species 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000005241 Cistus ladanifer Nutrition 0.000 description 1
- 240000008772 Cistus ladanifer Species 0.000 description 1
- 241000911175 Citharexylum caudatum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 244000166675 Cymbopogon nardus Species 0.000 description 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
- 241000252231 Cyprinus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241001621164 Ericameria pinifolia Species 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- MBMLMWLHJBBADN-UHFFFAOYSA-N Ferrous sulfide Chemical compound [Fe]=S MBMLMWLHJBBADN-UHFFFAOYSA-N 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000004869 Labdanum Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 241000238633 Odonata Species 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000206613 Pyropia yezoensis Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- VKCLPVFDVVKEKU-UHFFFAOYSA-N S=[P] Chemical compound S=[P] VKCLPVFDVVKEKU-UHFFFAOYSA-N 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000005083 Zinc sulfide Substances 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- DRHYDSJKKDNMCR-UHFFFAOYSA-N [S-][S-].[Ca+2] Chemical compound [S-][S-].[Ca+2] DRHYDSJKKDNMCR-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940008075 allyl sulfide Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- UYJXRRSPUVSSMN-UHFFFAOYSA-P ammonium sulfide Chemical compound [NH4+].[NH4+].[S-2] UYJXRRSPUVSSMN-UHFFFAOYSA-P 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- HSNWZBCBUUSSQD-UHFFFAOYSA-N amyl nitrate Chemical compound CCCCCO[N+]([O-])=O HSNWZBCBUUSSQD-UHFFFAOYSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 235000012665 annatto Nutrition 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- CJDPJFRMHVXWPT-UHFFFAOYSA-N barium sulfide Chemical compound [S-2].[Ba+2] CJDPJFRMHVXWPT-UHFFFAOYSA-N 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- JGIATAMCQXIDNZ-UHFFFAOYSA-N calcium sulfide Chemical compound [Ca]=S JGIATAMCQXIDNZ-UHFFFAOYSA-N 0.000 description 1
- FAYYUXPSKDFLEC-UHFFFAOYSA-L calcium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [Ca+2].[O-]S([O-])(=O)=S FAYYUXPSKDFLEC-UHFFFAOYSA-L 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical group 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 229940013361 cresol Drugs 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- CEJLBZWIKQJOAT-UHFFFAOYSA-N dichloroisocyanuric acid Chemical compound ClN1C(=O)NC(=O)N(Cl)C1=O CEJLBZWIKQJOAT-UHFFFAOYSA-N 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- FGRVOLIFQGXPCT-UHFFFAOYSA-L dipotassium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [K+].[K+].[O-]S([O-])(=O)=S FGRVOLIFQGXPCT-UHFFFAOYSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- 229940079896 disodium hydrogen citrate Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000019524 disodium tartrate Nutrition 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical compound O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- 229940076263 indole Drugs 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000177 juniperus communis l. berry Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- DPLVEEXVKBWGHE-UHFFFAOYSA-N potassium sulfide Chemical compound [S-2].[K+].[K+] DPLVEEXVKBWGHE-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 1
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- YPMOSINXXHVZIL-UHFFFAOYSA-N sulfanylideneantimony Chemical compound [Sb]=S YPMOSINXXHVZIL-UHFFFAOYSA-N 0.000 description 1
- 150000004763 sulfides Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- AFNRRBXCCXDRPS-UHFFFAOYSA-N tin(ii) sulfide Chemical compound [Sn]=S AFNRRBXCCXDRPS-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000019263 trisodium citrate Nutrition 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
- DRDVZXDWVBGGMH-UHFFFAOYSA-N zinc;sulfide Chemical compound [S-2].[Zn+2] DRDVZXDWVBGGMH-UHFFFAOYSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、炭酸水素ナトリウム、炭酸ナトリウム、有機酸、カチオン化ポリマーを含有し、特定の打錠硬度と吸液時間Aを有する打錠剤や、その原料である炭酸水素ナトリウムおよび、この炭酸水素ナトリウムを使用する打錠剤の製造方法に関する。 The present invention relates to a tablet containing sodium bicarbonate, sodium carbonate, an organic acid, and a cationized polymer, having a specific tableting hardness and liquid absorption time A, sodium bicarbonate as a raw material thereof, and the sodium bicarbonate. The present invention relates to a method for producing a compressed tablet.
従来から、炭酸水素ナトリウムを含有する打錠剤は、入浴剤、洗浄剤、農薬製剤、医薬品製剤、菓子類などとして広く使用されている。入浴剤については、近年浴湯に芳香や色調を与え入浴の気分を爽快にする他、新陳代謝を活発にして冷え性などを改善、温浴効果を得る目的で、浴湯に入浴剤を入れることが一般に普及しており、バスソルト、タブレット、液剤など各種形態のものが販売されている。その中でも、炭酸塩と酸とを組み合わせた炭酸ガス発生物を配合した入浴剤は、浴湯中で発生した炭酸ガスにより毛細血管を拡張し、新陳代謝を増進させるために、血行促進や疲労回復等の効果が期待され、その多くは打錠剤の形態で流通している。
打錠剤は、粉末原料を高い圧力をかけて製剤成型する製造方法が一般的である。この製造方法において、打錠硬度が打錠剤の保形性を向上するために重要なポイントとなってくる。打錠硬度が低いと亀裂や割れ等が生じやすく、製造時、保管時および輸送時等に破損が発生する一方で、打錠硬度が高すぎると崩壊性が悪化し、打錠剤としての機能を発揮できないという問題が起きるためである。適正な打錠硬度を得るために、入浴剤、洗浄剤、農薬製剤、医薬品製剤、菓子類などの分野において、各種アプローチが提案されている(例えば、特許文献1〜5等)ものの、これらの提案は、各分野における特定の錠剤について、その錠剤硬度や崩壊性を改善するものであるため、組成が異なる他の錠剤に適用することは困難であった。
Conventionally, tableting containing sodium bicarbonate has been widely used as a bath agent, detergent, agrochemical formulation, pharmaceutical formulation, confectionery, and the like. As for bathing agents, in recent years it has been common to add bathing agents to bathing baths for the purpose of obtaining a hot bath effect, in addition to refreshing the mood of bathing by adding aroma and color to bathing baths, in addition to improving metabolism and improving cooling properties. It is widespread, and various forms such as bath salts, tablets, and liquids are sold. Among them, bathing agents containing a carbon dioxide generator that combines carbonates and acids expand blood vessels by carbon dioxide generated in the bath water and promote metabolism, recovery of fatigue, etc. Many of them are expected to be distributed in the form of tableted tablets.
A tableting tablet is generally produced by a method in which a powder material is molded by applying a high pressure. In this production method, the tableting hardness is an important point for improving the shape retention of the tablet. If the tableting hardness is low, cracks and cracks are likely to occur, and breakage occurs during production, storage, and transportation.On the other hand, if the tableting hardness is too high, the disintegration property deteriorates and functions as a tablet. This is because there is a problem that it cannot be demonstrated. In order to obtain an appropriate tableting hardness, various approaches have been proposed in the fields of bathing agents, cleaning agents, agricultural chemical formulations, pharmaceutical formulations, confectionery, etc. (for example, Patent Documents 1 to 5). Since the proposal improves the tablet hardness and disintegration of a specific tablet in each field, it has been difficult to apply it to other tablets having different compositions.
入浴剤の中でも、カチオン化ポリマーを配合した入浴剤は、天然温泉に入浴したような肌が浴湯をまとう感触や入浴後に肌にしっとり感が得られるなど、天然温泉を模した入浴剤の1つとして好評を得ている。また、カチオン化ポリマーは、化粧品・香粧品分野、特にシャンプーにはコンディショニング基剤のひとつとして汎用的に使用されている。しかしながら、本発明者は、カチオン化ポリマーを配合することにより、打錠剤の打錠硬度が大きく低下することを実験により把握していた。
そこで本発明は、このカチオン化ポリマーと、炭酸塩と酸からなる炭酸ガス発生物とを組み合わせた、製剤安定性が高く、かつ、崩壊性も良好な打錠剤を提供することを課題としている。
Among bathing agents, bathing agents formulated with cationized polymers are one of the bathing agents that mimic natural hot springs, such as the feeling of bathing in natural hot springs and the moist feeling of the skin after bathing. It has gained popularity as one. In addition, cationized polymers are widely used as a conditioning base in the cosmetics and cosmetics fields, particularly in shampoos. However, the present inventor has known from experiments that the tableting hardness of the tableting is greatly reduced by blending the cationized polymer.
Accordingly, an object of the present invention is to provide a tableting that combines the cationized polymer with a carbon dioxide gas generator composed of a carbonate and an acid and has high formulation stability and good disintegration.
本発明者は、炭酸水素ナトリウム、炭酸ナトリウム、有機酸、カチオン化ポリマーを含有する打錠剤について種々検討した結果、全く意外なことに、その打錠硬度を特定値以上のものとし、下記に詳細説明する吸液時間Aを特定の範囲内のものとすることにより、製造時、保管時および輸送時に破損等が発生しない保形性に優れること、さらには、打錠硬度が高くなると崩壊性が悪化することが打錠剤分野における技術常識にも関わらず、本発明の打錠剤は、錠剤崩壊性にも優れること、すなわち、特定の打錠硬度により保形性と崩壊性の両立が得られることを見出し、本発明を完成するに至った。
また、本発明者は、特定の結晶を含有し、かつ、特定のかさ比重である炭酸水素ナトリウムを、本発明のカチオン化ポリマーを含有する打錠剤の原料として使用することにより、特異的に打錠硬度を向上し得ることも見出した。
As a result of various studies on tableting containing sodium hydrogen carbonate, sodium carbonate, organic acid, and cationized polymer, the present inventor has surprisingly set the tableting hardness to a specific value or more and is described in detail below. By making the liquid absorption time A to be described within a specific range, it is excellent in shape retention that does not cause breakage during production, storage, and transportation, and further, disintegration occurs when the tableting hardness increases. Despite the technical common sense in the tableting field, the tableting of the present invention is also excellent in tablet disintegration, that is, both shape retention and disintegration can be obtained by specific tableting hardness. As a result, the present invention has been completed.
In addition, the present inventor specifically uses sodium hydrogen carbonate containing a specific crystal and having a specific bulk specific gravity as a raw material for tableting containing the cationized polymer of the present invention. It has also been found that the tablet hardness can be improved.
本発明は、具体的には次の事項を要旨とする。
1.炭酸水素ナトリウム、炭酸ナトリウム、有機酸、カチオン化ポリマーを含有し、打錠硬度が2kgf以上であり、かつ、下記吸液時間Aが45分以上65分以下であることを特徴とする打錠剤。
吸液時間A:環境温度25℃において、流動パラフィン5mlを入れた直径90mmのシャーレーに、直径30mm、全量15gの円柱状打錠剤の、円形の天面と底面が流動パラフィンの液面に対して垂直となるように載置してから、流動パラフィンが打錠剤の最頂点に到達するまでの時間
2.下記a線と下記b線との比(a線/b線)の平均が2以上4以下であり、かつ、かさ比重が1.05g/mL以下であることを特徴とする、1.に記載の打錠剤用原料としての炭酸水素ナトリウム。
a線:1つの炭酸水素ナトリウムの結晶の端と端とを結ぶ直線が最長となる対端線
b線:a線と直交する直線が最長となる対端線
3.下記a線と下記b線との比(a線/b線)の平均が2以上4以下であり、かつ、かさ比重が1.05g/mL以下である炭酸水素ナトリウムを原料として使用することを特徴とする、1.に記載の打錠剤の製造方法。
a線:1つの炭酸水素ナトリウムの結晶の端と端とを結ぶ直線が最長となる対端線
b線:a線と直交する直線が最長となる対端線
4.下記a線と下記b線との比(a線/b線)の平均が2以上4以下であり、かつ、かさ比重が1.05g/mL以下である炭酸水素ナトリウム、炭酸ナトリウム、有機酸、カチオン化セルロースを打錠することにより得られる、1.に記載の打錠剤。
a線:1つの炭酸水素ナトリウムの結晶の端と端とを結ぶ直線が最長となる対端線
b線:a線と直交する直線が最長となる対端線
The gist of the present invention is specifically as follows.
1. A tableting composition comprising sodium bicarbonate, sodium carbonate, an organic acid, a cationized polymer, having a tableting hardness of 2 kgf or more, and a liquid absorption time A of 45 minutes to 65 minutes.
Liquid absorption time A: At an environmental temperature of 25 ° C., a circular shaped tablet with a diameter of 30 mm and a total amount of 15 g in a 90 mm diameter petri dish containing 5 ml of liquid paraffin, and the top and bottom surfaces of the circle with respect to the liquid paraffin liquid level 1. Time from the time when the paraffin is placed vertically until the liquid paraffin reaches the top of the tablet. The ratio of the following a line and the following b line (a line / b line) has an average of 2 or more and 4 or less, and a bulk specific gravity of 1.05 g / mL or less. Sodium bicarbonate as a raw material for tableting as described in 1.
Line a: the opposite end line having the longest straight line connecting the ends of one sodium bicarbonate crystal b line: the opposite end line having the longest straight line orthogonal to the line a The average of the ratio of the following a line and the following b line (a line / b line) is 2 or more and 4 or less, and uses sodium hydrogencarbonate whose bulk specific gravity is 1.05 g / mL or less as a raw material. Features 1. The manufacturing method of the tablet as described in 1 ..
Line a: the opposite end line where the straight line connecting the ends of one sodium hydrogen carbonate crystal is the longest line b: the opposite end line where the straight line orthogonal to the a line is the longest Sodium bicarbonate, sodium carbonate, organic acid, wherein the average of the ratio of the following a line and the following b line (a line / b line) is 2 or more and 4 or less and the bulk specific gravity is 1.05 g / mL or less, Obtained by tableting cationized cellulose; Tablets as described in 1.
Line a: the opposite end line where the straight line connecting the ends of one sodium bicarbonate crystal is the longest line b: The end line where the straight line orthogonal to the line a is the longest
本発明の打錠剤は、その製造時、保管時および輸送時に亀裂や割れ等の破損が生じることがなく、優れた保形性を発揮するのみならず、この優れた保形性により、空気との接触面を最低限に抑制できるため、保存安定性をも向上するなど、製剤安定性に極めて優れた効果を発揮する。
発泡性打錠剤は、その打錠硬度が向上すると、水中に投入した際の錠剤崩壊性が悪化し、発生した炭酸ガスが効率よく水中に溶解させられないことが知られているが、本発明の打錠剤は、打錠硬度が高いにも関わらず、良好な錠剤崩壊性が得られ、発生する炭酸ガスを効率よく水中に溶解させることができる。
すなわち、本発明の打錠剤は、製剤安定性と崩壊性の両立が図られており、極めて有用である。
The tableting of the present invention does not cause breakage such as cracks or cracks during production, storage and transportation, and not only exhibits excellent shape retention, but also due to this excellent shape retention, The contact surface can be suppressed to a minimum, so that the storage stability is improved and the formulation stability is extremely excellent.
It is known that when the tableting hardness of the effervescent tablet is improved, the disintegration property of the tablet when introduced into water deteriorates, and the generated carbon dioxide gas cannot be efficiently dissolved in water. Although the tableting tablet has a high tableting hardness, good tablet disintegration can be obtained, and the generated carbon dioxide gas can be efficiently dissolved in water.
That is, the tableted tablet of the present invention is extremely useful because it is compatible with formulation stability and disintegration.
以下、本発明の打錠剤について詳細に説明する。
本発明の打錠剤は、炭酸水素ナトリウム、炭酸ナトリウム、有機酸、カチオン化ポリマーを組み合わせ、打錠硬度を2kgf以上の打錠剤とし、かつ、吸液時間Aを45分以上65分以下とすることが、製剤安定性と崩壊性の両立を図るために重要である。
本発明の打錠剤において、打錠硬度を2kgf以上、かつ、吸液時間Aを45分以上65分以下とできれば、特に限定されず如何なる炭酸水素ナトリウム、炭酸ナトリウム、有機酸、カチオン化ポリマーも使用することができる。
Hereinafter, the tableting of the present invention will be described in detail.
The tableting of the present invention is a combination of sodium bicarbonate, sodium carbonate, organic acid and cationized polymer, tableting hardness of 2 kgf or more, and liquid absorption time A of 45 minutes or more and 65 minutes or less. However, it is important for achieving both the stability of the preparation and the disintegration property.
In the tableting of the present invention, any sodium hydrogen carbonate, sodium carbonate, organic acid, cationized polymer may be used as long as the tableting hardness is 2 kgf or more and the liquid absorption time A is 45 minutes or more and 65 minutes or less. can do.
<炭酸水素ナトリウム>
炭酸水素ナトリウムは、中でも、以下に説明する特定の結晶を含有し、かつ、特定のかさ比重である炭酸水素ナトリウムを使用すると、本発明の打錠剤の打錠硬度を2kgf以上、かつ、吸液時間Aを45分以上65分以下とすることができ、好適である。
以下に説明する「a線とb線との比(a線/b線)」の平均が2以上4以下である炭酸水素ナトリウムを使用すると、本発明の打錠剤の硬度を向上する点において好ましい。
(a線/b線について)
本発明におけるa線とb線は、炭酸水素ナトリウムを顕微鏡で観察し1つの結晶に着目して画像解析を行う。図1により詳しく説明すると、a線は、図1の左右両図中の実線で示すように、1つの炭酸水素ナトリウムの結晶の端と端とを結ぶ直線が最長となる対端線を意味し、b線は、図1の左右両図中の点線で示すように、このa線と直交する直線が最長となる対端線を意味する。
a線とb線との比(a線/b線)は、a線の値をb線の値により除して算出した値である。顕微鏡により異なる15個の結晶に対して、この観察と計測算出を行い、その平均値を本発明のa線とb線との比(a線/b線)の平均とした。
炭酸水素ナトリウムのa線とb線との比(a線/b線)の平均が2以上4以下のものが好ましいが、中でも、2以上3以下であることがより好ましく、2以上2.5以下であることが特に好ましい。
また、本発明の打錠剤に使用する炭酸水素ナトリウムは、炭酸水素ナトリウム全量に対し、a線とb線との比(a線/b線)が2以上4以下の結晶を30%以上含有することが好ましく、40%以上含有することがより好ましく、50%以上含有することが特に好ましい。当該結晶の含有量は、炭酸水素ナトリウムを顕微鏡で観察した画像を解析することにより求めることができる。
<Sodium bicarbonate>
Among them, sodium bicarbonate contains the specific crystals described below and has a specific bulk specific gravity. When sodium bicarbonate is used, the tableting hardness of the tablet of the present invention is 2 kgf or more, and the liquid absorption The time A can be set to 45 minutes or more and 65 minutes or less, which is preferable.
Use of sodium bicarbonate having an average of “ratio between a line and b line (a line / b line)” described below of 2 or more and 4 or less is preferable in terms of improving the hardness of the tableting of the present invention. .
(About a line / b line)
The a line and the b line in the present invention perform image analysis by observing sodium hydrogen carbonate with a microscope and paying attention to one crystal. Describing in more detail with reference to FIG. 1, the a line means the opposite end line having the longest straight line connecting the ends of one sodium hydrogencarbonate crystal, as shown by the solid lines in the left and right views of FIG. , B lines mean the opposite end line where the straight line orthogonal to the a line is the longest, as shown by the dotted lines in the left and right diagrams of FIG.
The ratio of the a line to the b line (a line / b line) is a value calculated by dividing the value of the a line by the value of the b line. This observation and measurement calculation were performed on 15 different crystals by a microscope, and the average value was taken as the average of the ratio of a line to b line (a line / b line) of the present invention.
The average of the ratio of a-line to b-line (a-line / b-line) of sodium hydrogen carbonate is preferably 2 or more and 4 or less, more preferably 2 or more and 3 or less, and more preferably 2 or more and 2.5. It is particularly preferred that
Moreover, the sodium hydrogencarbonate used for the tableting of the present invention contains 30% or more of crystals having a ratio of a line to b line (a line / b line) of 2 to 4 with respect to the total amount of sodium hydrogen carbonate. The content is preferably 40% or more, more preferably 50% or more. The content of the crystal can be determined by analyzing an image obtained by observing sodium bicarbonate with a microscope.
以下に説明する「かさ比重」が1.05g/mL以下である炭酸水素ナトリウムを使用すると、本発明の打錠剤の硬度を向上する点において好ましい。
(かさ比重について)
本発明のかさ比重は、一般に、ゆるみかさ比重(密度)といわれるものである。炭酸水素ナトリウムを容量100mLの容器に、タッピングすることなく「ゆるく」すりきり一杯に充填し、充填された炭酸水素ナトリウムの重量を測定することにより算出することができる。
炭酸水素ナトリウムのかさ比重の上限値は1.05g/mL以下のものが好ましいが、中でも、1.01g/mL以下であることがより好ましく、0.95g/mL以下であることが特に好ましい。また、このかさ比重の下限値は、0.70g/mL以上であることが好ましく、0.75g/mL以上であることがより好ましく、0.80g/mL以上であることが特に好ましい。
Use of sodium bicarbonate having a “bulk specific gravity” of 1.05 g / mL or less, which will be described below, is preferable in terms of improving the hardness of the tableting of the present invention.
(About bulk specific gravity)
The bulk specific gravity of the present invention is generally referred to as loose bulk specific gravity (density). It can be calculated by filling sodium hydrogencarbonate into a 100 mL capacity container “loosely” without tapping and measuring the weight of the filled sodium hydrogencarbonate.
The upper limit of the bulk specific gravity of sodium hydrogencarbonate is preferably 1.05 g / mL or less, more preferably 1.01 g / mL or less, and particularly preferably 0.95 g / mL or less. The lower limit of the bulk specific gravity is preferably 0.70 g / mL or more, more preferably 0.75 g / mL or more, and particularly preferably 0.80 g / mL or more.
また、本発明の打錠剤に使用する炭酸水素ナトリウムは、特定の圧縮率であることが好ましい。
本発明における圧縮率は、以下の測定方法および計算式により算出される。
(1)炭酸水素ナトリウムを15g秤量し、これを底辺の面積が7.11cm2の円筒形の臼に充填した。
(2)充填した上記(1)の炭酸水素ナトリウムの高さを、上述の本発明のかさ比重により算出し、圧縮前の厚みとした。
(3)油圧ポンプ式打錠機にて、25kNの圧力で圧縮した後の炭酸水素ナトリウムの厚みを測定し、圧縮後の厚みとした。
[圧縮率の計算式]
圧縮率(%)=(圧縮前の厚み−圧縮後の厚み)÷圧縮前の厚み
本発明の打錠剤に使用する炭酸水素ナトリウムは、この圧縮率の下限値が35%以上であることが好ましく、36%以上であることがより好ましく、37%以上であることが特に好ましい。また、この圧縮率の上限値は50%以下であることが好ましく、48%以下であることがより好ましく、45%以下であることが特に好ましい。
さらに、本発明の打錠剤に使用する炭酸水素ナトリウムは、平均粒子径が150μmより大きいことが、打錠硬度を向上する点において好ましい。
Moreover, it is preferable that the sodium hydrogencarbonate used for the tableting of this invention is a specific compression rate.
The compression rate in the present invention is calculated by the following measurement method and calculation formula.
(1) 15 g of sodium bicarbonate was weighed and filled into a cylindrical mortar having a base area of 7.11 cm 2 .
(2) The height of the filled sodium hydrogen carbonate of (1) was calculated by the bulk specific gravity of the present invention described above, and was defined as the thickness before compression.
(3) The thickness of the sodium hydrogen carbonate after being compressed at a pressure of 25 kN was measured with a hydraulic pump tableting machine, and the thickness after compression was determined.
[Calculation formula for compression ratio]
Compression rate (%) = (Thickness before compression−Thickness after compression) ÷ Thickness before compression The sodium bicarbonate used in the tableting of the present invention preferably has a lower limit value of 35% or more. 36% or more, more preferably 37% or more. Further, the upper limit value of the compression rate is preferably 50% or less, more preferably 48% or less, and particularly preferably 45% or less.
Furthermore, the sodium hydrogen carbonate used for the tableting of the present invention preferably has an average particle size larger than 150 μm in terms of improving tableting hardness.
本発明の打錠剤に使用する炭酸水素ナトリウム、特に、a線とb線との比(a線/b線)の平均が2以上4以下であり、かつ、かさ比重が1.05g/mL以下の炭酸水素ナトリウムは、これらの規定を満たすものであれば、市販品を含め何れのものでも採用することができる。さらに、規定を満たさない炭酸水素ナトリウムであっても、例えば、篩による分級や破砕等の手段により、これらの規定を満たす炭酸水素ナトリウムとすることができる。
a線とb線との比(a線/b線)の平均が2以上4以下であり、かつ、かさ比重が1.05g/mL以下の炭酸水素ナトリウムのみを15g使用して、7.11cm2の円筒形の臼に充填し、油圧ポンプ式打錠機にて25kNの圧力で圧縮することにより得られた打錠剤の硬度は、4.0kgf以上6.0kgf以下の範囲であった。
本発明の打錠剤において、炭酸水素ナトリウムは、打錠剤の全重量に対して、20重量%以上75重量%以下の範囲であることが好ましく、40重量%以上65重量%以下の範囲がより好ましい。
Sodium bicarbonate used in the tableting of the present invention, in particular, the average of the ratio of a line to b line (a line / b line) is 2 or more and 4 or less, and the bulk specific gravity is 1.05 g / mL or less. Any sodium bicarbonate can be used as long as it satisfies these regulations, including commercially available products. Furthermore, even if it is sodium hydrogencarbonate which does not satisfy | fill a prescription | regulation, it can be set as sodium hydrogencarbonate which satisfy | fills these prescription | regulations, for example by means, such as classification and crushing with a sieve.
The average of the ratio of a line to b line (a line / b line) is 2 or more and 4 or less, and 15 g of sodium bicarbonate having a bulk specific gravity of 1.05 g / mL or less is used. filling the die of the second cylindrical, the hardness of the striking tablets obtained by compressing at a pressure of 25kN by a hydraulic pump type tabletting machine was 6.0kgf following range of 4.0 kgf.
In the tableting of the present invention, sodium bicarbonate is preferably in the range of 20% by weight to 75% by weight and more preferably in the range of 40% by weight to 65% by weight with respect to the total weight of the tableting. .
<炭酸ナトリウムについて>
本発明の打錠剤において、炭酸ナトリウムは無水物を使用することが好ましく、打錠剤全重量に対して3重量%以上20重量%以下の範囲であることが好ましく、5重量%以上10重量%以下の範囲がより好ましい。
本発明の打錠剤に使用する炭酸ナトリウムは、平均粒子径が150μmより大きいことが、打錠硬度を向上する点において好ましい。
<有機酸について>
本発明の打錠剤において、含有する有機酸としては、フマル酸、クエン酸、リンゴ酸、酒石酸、コハク酸、マレイン酸、フタル酸、グルタル酸、アジピン酸、安息香酸、サリチル酸およびシュウ酸から選ばれる1種または2種以上が挙げられる。中でも、製剤安定性の観点から、フマル酸および/またはコハク酸がより好ましい。
本発明の打錠剤において、有機酸の配合量は、打錠剤全重量に対して10重量%以上75重量%以下の範囲であることが好ましく、20重量%以上55重量%以下の範囲がより好ましく、さらに、30重量%より少なく含有することが特に好ましい。
<About sodium carbonate>
In the tableting of the present invention, it is preferable to use an anhydrous sodium carbonate, preferably in the range of 3% by weight to 20% by weight with respect to the total weight of the tableting, and 5% by weight or more and 10% by weight or less. The range of is more preferable.
The sodium carbonate used for the tableting of the present invention preferably has an average particle size larger than 150 μm in terms of improving tableting hardness.
<About organic acids>
In the tablet of the present invention, the organic acid contained is selected from fumaric acid, citric acid, malic acid, tartaric acid, succinic acid, maleic acid, phthalic acid, glutaric acid, adipic acid, benzoic acid, salicylic acid and oxalic acid. 1 type or 2 types or more are mentioned. Among these, fumaric acid and / or succinic acid are more preferable from the viewpoint of formulation stability.
In the tableting of the present invention, the amount of the organic acid is preferably in the range of 10% by weight to 75% by weight and more preferably in the range of 20% by weight to 55% by weight with respect to the total weight of the tableting. Furthermore, it is particularly preferable to contain less than 30% by weight.
<カチオン化ポリマーについて>
本発明の打錠剤に使用できるカチオン化ポリマーとしては、市場で入手することのできるものを例示することができる。
カチオン化セルロースとしては、例えば、塩化O−[2−ヒドロキシ−3−(トリメチルアンモニオ)プロピル]ヒドロキシエチルセルロース、塩化O−[2−ヒドロキシ−3−(ラウリルジメチルアンモニオ)プロピル]ヒドロキシエチルセルロース、塩化ジメチルジアリルアンモニウム・ヒドロキシエチルセルロース共重合体等が、カチオン化グアーガムとしては、例えば、塩化O−[2−ヒドロキシ−3−(トリメチルアンモニオ)プロピル]グアーガムが、カチオン化デキストランとしては、例えば、デキストラン塩化ヒドロキシプロピルトリメチルアンモニウムエーテルが、カチオン化アクリルアミド共重合体としては、例えば、塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体が、カチオン化コラーゲンとしては、例えば、塩化N−[2−ヒドロキシ−3−(トリメチルアンモニオ)プロピル]加水分解コラーゲンが、その他、カチオン化でんぷんが挙げられる。
これらの中でも、カチオン化セルロース、カチオン化グアーガムまたはカチオン化デキストランが、入浴剤として使用する場合には天然温泉を模した浴湯の感触が得られる点と、水への溶解性の点で好ましい。特に、カチオン化セルロースは、水への溶解性の点から、分子量10万〜200万、カチオン化度(1グルコース当たりに付加するカチオン基のモル数)0.1〜0.4のものが好ましい。本発明の打錠剤において、カチオン化ポリマーの配合量は、打錠剤全重量に対して好ましくは0.01〜3.0重量%であり、より好ましくは0.1〜2.0重量%であり、さらに好ましくは0.5〜1.0重量%である。
<About cationized polymers>
Examples of the cationized polymer that can be used in the tableting of the present invention include those available on the market.
Examples of the cationized cellulose include O- [2-hydroxy-3- (trimethylammonio) propyl] hydroxyethylcellulose chloride, O- [2-hydroxy-3- (lauryldimethylammonio) propyl] hydroxyethylcellulose chloride, and chloride. Dimethyldiallylammonium / hydroxyethylcellulose copolymer, etc., as cationized guar gum, for example, O- [2-hydroxy-3- (trimethylammonio) propyl] guar gum chloride, as cationized dextran, for example, dextran chloride Hydroxypropyltrimethylammonium ether is a cationized acrylamide copolymer. For example, dimethyldiallylammonium chloride / acrylamide copolymer is a cationized collagen. Eg to chloride N- [2- hydroxy-3- (trimethylammonio) propyl] hydrolyzed collagen, other, cationic starch.
Among these, cationized cellulose, cationized guar gum, or cationized dextran is preferable from the viewpoint of obtaining the feel of a hot spring that simulates a natural hot spring and the solubility in water when used as a bath agent. In particular, the cationized cellulose is preferably one having a molecular weight of 100,000 to 2,000,000 and a degree of cationization (number of moles of cation group added per glucose) of 0.1 to 0.4 from the viewpoint of solubility in water. . In the tableting of the present invention, the amount of the cationized polymer is preferably 0.01 to 3.0% by weight, more preferably 0.1 to 2.0% by weight based on the total weight of the tableting. More preferably, it is 0.5 to 1.0% by weight.
<打錠剤について>
本発明の打錠剤は、上記成分を混合し打錠することにより製造され、周知の打錠機を用いることができる。周知の打錠機は、臼の中に粉末混合物を充填し、下杵と上杵の間で圧縮して成形する装置である。打錠機には、1個の臼内で上下一組の杵が上下運動して圧縮する単発打錠機、水平に回転するターンテーブルの外周に、臼が等間隔に埋め込まれ、ターンテーブルが回転する間に、充填・圧縮・排出の一連の操作が連続的に行われるロータリー打錠機がある。周知の打錠機として、単発打錠機には志賀製作所製打錠機などを、ロータリー打錠機には株式会社菊水製作所製打錠機などを用いることができる。また、作製する錠剤の重量に合わせた杵臼と、例えば、ラボネクト株式会社、理研機器株式会社などの油圧式ポンプなどを用いて単発打錠し、打錠剤を作製することもできる。打錠方法は制限されるべきでなく、直接粉末打錠法(直打法)や顆粒打錠法(間接圧縮法)により製造することができる。また、各成分の混合の順序や混合方法等は適宜選定される。
打錠機を用いるときの錠剤の大きさは、円柱状の場合には直径(多角形の場合には1辺の長さ)が80mm以下のものが好ましく、60mm以下がより好ましく、また、10mm以上が好ましく、30mm以上がより好ましい。錠剤の厚みは、20mm以下が好ましく、17mm以下がより好ましく、また、5mm以上が好ましく、8mm以上がより好ましく、10mm以上がさらに好ましい。錠剤の形状は、特に限定されるものではないが、円柱状、ブロック状、球状、半球形状、多角体形状等より選択されるが、円柱状が好ましい。
<About tableting>
The tableting of the present invention is produced by mixing the above components and tableting, and a known tableting machine can be used. A known tableting machine is an apparatus in which a powder mixture is filled in a mortar and compressed between a lower punch and an upper punch and molded. A tableting machine is a single-punch tableting machine in which a pair of upper and lower punches move up and down within a single die, and a die is embedded in the outer periphery of a horizontally rotating turntable at equal intervals. There is a rotary tableting machine in which a series of operations of filling, compression, and discharging are continuously performed while rotating. As a known tableting machine, a tableting machine manufactured by Shiga Manufacturing Co., Ltd. can be used as a single tableting machine, and a tableting machine manufactured by Kikusui Manufacturing Co., Ltd. can be used as a rotary tableting machine. In addition, a tablet can be produced by single-punching using a mortar matched to the weight of the tablet to be produced and a hydraulic pump such as RaboNect Co., Ltd., Riken Kikai Co., Ltd., or the like. The tableting method should not be limited, and can be produced by a direct powder tableting method (direct compression method) or a granule tableting method (indirect compression method). Further, the order of mixing the components, the mixing method, and the like are appropriately selected.
The tablet size when using a tableting machine is preferably 80 mm or less, more preferably 60 mm or less, and more preferably 10 mm or less in the case of a cylindrical shape (in the case of a polygon, the length of one side). The above is preferable, and 30 mm or more is more preferable. The thickness of the tablet is preferably 20 mm or less, more preferably 17 mm or less, more preferably 5 mm or more, more preferably 8 mm or more, and even more preferably 10 mm or more. The shape of the tablet is not particularly limited, but is selected from a cylindrical shape, a block shape, a spherical shape, a hemispherical shape, a polygonal shape, and the like, and a cylindrical shape is preferable.
<打錠硬度について>
本発明の打錠剤の打錠硬度は、打錠剤の縦方向(直径方向)に対して、フォースゲージ(例えば、デジタルフォースゲージ:MODEL−RZ−50、アイコーエンジニアリング株式会社製)を用いて圧力をかけていき、亀裂やひびが生じる時の最大圧力を意味する。
具体的には下記に記載の15g打錠剤での打錠硬度測定方法に従い測定する。
<15g打錠剤での打錠硬度測定方法>
直径30mm、厚さ約15mm、全量15gの25kNの圧力で打錠した円柱状打錠剤の側面(直径方向)に対して、下記の測定条件にて圧力をかけていき、亀裂やひびが生じる時の最大圧力を測定する。
[測定条件]
・デジタルフォースゲージ:MODEL−RZ−50(アイコーエンジニアリング株式会社製)
・電動スタンド:MODEL−1308U(アイコーエンジニアリング株式会社製)
・計測用アタッチメント:012B(円形、直径15mm)
・計測時の電動スタンド速度:5mm/min
本発明の打錠剤は、上記測定方法により計測した打錠硬度が2kgf以上のものである。中でも、2.5kgf以上のものが好ましく、3kgf以上のものがより好ましい。本発明の打錠剤の打錠硬度の上限値は、6.5kgf以下が好ましく、6.0kgf以下がより好ましい。
<About tableting hardness>
The tableting hardness of the tableting of the present invention is determined by applying a force gauge (for example, digital force gauge: MODEL-RZ-50, manufactured by Aiko Engineering Co., Ltd.) to the longitudinal direction (diameter direction) of the tableting. It means the maximum pressure when cracks and cracks occur.
Specifically, it is measured according to the tableting hardness measurement method for 15 g tableting described below.
<Method for measuring tablet hardness with 15 g tablet>
When cracks and cracks occur when pressure is applied under the following measurement conditions to the side (diameter direction) of a cylindrical tablet that is 30mm in diameter, approximately 15mm in thickness, and tableted at a pressure of 25kN. Measure the maximum pressure.
[Measurement condition]
-Digital force gauge: MODEL-RZ-50 (manufactured by Aiko Engineering Co., Ltd.)
-Motorized stand: MODEL-1308U (manufactured by Aiko Engineering Co., Ltd.)
・ Measurement attachment: 012B (circular, diameter 15 mm)
-Motorized stand speed during measurement: 5 mm / min
The tableting tablet of the present invention has a tableting hardness measured by the above measuring method of 2 kgf or more. Especially, the thing of 2.5 kgf or more is preferable, and the thing of 3 kgf or more is more preferable. The upper limit of the tableting hardness of the tableting of the present invention is preferably 6.5 kgf or less, and more preferably 6.0 kgf or less.
<吸液時間Aについて>
本発明の打錠剤は、下記に説明する吸液時間Aが、45分以上65分以下であることを特徴とするものである。
吸液時間Aは、直径30mm、厚さ約15mm、全量15gの25kNの圧力で打錠した円柱状打錠剤を、流動パラフィン5mlを入れた直径90mmのシャーレーに、円形の天面と底面が流動パラフィンの液面に対して垂直となるように載置して、載置直後から流動パラフィンが打錠剤の最頂点に到達するまでの時間を意味する。
この吸液時間Aを測定するために使用する流動パラフィンは、37.8℃における動粘度が8〜17mm2/sのものであれば良く、例えば、三光化学工業株式会社製の流動パラフィンNo.70-S等が例示できる。
本発明の打錠剤の吸液時間Aは、45分以上65分以下であることを特徴とし、中でも、45分以上60分以下であることが好ましい。
<空隙面積、空隙率について>
本発明の打錠剤の空隙面積の測定方法としては、特に限定されないが、例えば、その断面を画像解析することにより算出できる。具体的には、後述する具体例により詳細に説明するが、次のような測定方法を用いることができる。すなわち、直径30mm、厚さ約15mm、全量15gの25kNの圧力で打錠した円柱状打錠剤を直径部で概略2分割し、その断面の画像を原料相と気泡相(空隙部)とで二値化し、気泡相(空隙部)面積(mm2)を、本発明の空隙面積と見なすことができ、この画像解析より空隙率(%)を算出することもできる。
本発明の打錠剤は、後述の具体例における実空隙面積が0.15mm2以下の範囲であることが好ましい。また、後述の具体例における空隙率が2〜15%の範囲であることが好ましく、5〜15%の範囲であることがより好ましい。
<About liquid absorption time A>
The tableting of the present invention is characterized in that the liquid absorption time A described below is 45 minutes or more and 65 minutes or less.
The liquid absorption time A is a cylindrical tablet formed by pressing with a pressure of 25 kN with a diameter of 30 mm, a thickness of about 15 mm, and a total amount of 15 g. A circular top and bottom flow into a 90 mm diameter petri dish containing 5 ml of liquid paraffin. It means the time from the time when the paraffin is placed so as to be perpendicular to the liquid surface of paraffin to the time when the liquid paraffin reaches the top of the tablet.
The liquid paraffin used to measure the liquid absorption time A may be any liquid paraffin having a kinematic viscosity of 8 to 17 mm 2 / s at 37.8 ° C., for example, liquid paraffin No. manufactured by Sanko Chemical Co., Ltd. 70-S can be exemplified.
The liquid absorption time A of the tableting of the present invention is 45 minutes or more and 65 minutes or less, and preferably 45 minutes or more and 60 minutes or less.
<About void area and porosity>
The method for measuring the void area of the tableting of the present invention is not particularly limited, and can be calculated, for example, by image analysis of the cross section. Specifically, although it demonstrates in detail by the specific example mentioned later, the following measuring methods can be used. That is, a cylindrical tablet that was compressed with a pressure of 25 kN, having a diameter of 30 mm, a thickness of about 15 mm, and a total amount of 15 g, was roughly divided into two parts at the diameter part, and the cross-sectional image was divided into two parts, the raw material phase and the cell phase (void part). The bubble phase (void part) area (mm 2 ) can be regarded as the void area of the present invention, and the void ratio (%) can also be calculated from this image analysis.
In the tableting of the present invention, the actual void area in the specific examples described later is preferably in the range of 0.15 mm 2 or less. Moreover, it is preferable that the porosity in the below-mentioned specific example is the range of 2-15%, and it is more preferable that it is the range of 5-15%.
本発明の打錠剤は、入浴剤、義歯洗浄剤、水洗トイレ用洗浄剤、排水口用洗浄剤などの発泡洗浄剤、水田用ジャンボ剤などの農薬製剤、発泡性菓子の他、ヘッドスパ用途等にも使用することが可能である。
本発明の打錠剤を入浴剤として使用する場合には、上述した炭酸水素ナトリウム、炭酸ナトリウム、有機酸、カチオン化ポリマーの他に、必要に応じて、入浴剤の分野で知られている各種成分(以下「任意成分」と称することもある)を1種または2種以上組み合せて含有することができる。以下に本発明の打錠剤を入浴剤とする場合に含有することのできる任意成分を例示するが、ここに記載された成分等に限定されないことは言うまでもない。
The tableted tablet of the present invention is used for bathing agents, denture cleaning agents, flushing toilet cleaning agents, foam cleaning agents such as drain outlet cleaning agents, agrochemical preparations such as paddy field jumbo agents, foaming confectionery, head spa use, etc. Can also be used.
When the tableted tablet of the present invention is used as a bath agent, in addition to the above-mentioned sodium hydrogen carbonate, sodium carbonate, organic acid, cationized polymer, various components known in the bath agent field as necessary. (Hereinafter also referred to as “optional component”) may be contained alone or in combination of two or more. Although the arbitrary component which can be contained when using the tableting of this invention as a bath agent below is illustrated, it cannot be overemphasized that it is not limited to the component etc. which were described here.
<無機塩類(炭酸水素ナトリウムと炭酸ナトリウムを除く)>
塩化ナトリウム、塩化カリウム、塩化アンモニウム等の塩化物、セスキ炭酸ナトリウム、炭酸カルシウム、炭酸カリウム、炭酸マグネシウム、重質炭酸マグネシウム等の炭酸塩、硫酸ナトリウム、硫酸マグネシウム、硫酸アルミニウム、硫酸鉄、硫酸アルミニウムカリウム、チオ硫酸ナトリウム、チオ硫酸カルシウム、チオ硫酸カリウム、次亜硫酸ナトリウム等の硫酸塩、硝酸ナトリウム、硝酸カリウム、硝酸カルシウム等の硝酸塩、リン酸ナトリウム、リン酸水素カルシウム等のリン酸塩、ケイ酸カルシウム、ケイ酸マグネシウム、硫化カルシウム、重硫化カルシウム、硫化カリウム、硫化ナトリウム、硫化アンモニウム、硫化バリウム、硫化亜鉛、硫化スズ、硫化アンチモン、硫化鉄、二硫化炭素、硫化リン等の硫化物、水酸化ナトリウム、水酸化カルシウム等の水酸化物、ホウ砂、ホウ酸、酸化カルシウム、臭化カリウム、過マンガン酸カリウム等が挙げられる。上記無機塩類の中でも、塩化ナトリウム、硫酸ナトリウム、硫酸アルミニウムカリウム、硫酸マグネシウム、炭酸カルシウム、ケイ酸カルシウムが好適であり、特に、本発明の打錠剤を入浴剤とする場合には、硫酸ナトリウム、ケイ酸カルシウムを含有することが好ましく、これらは製剤助剤としても好適である。
<油性成分類>
ヌカ油、ホホバ油、オリーブ油、大豆油等の天然油脂;ワセリン、スクワラン、スクワレン等の炭化水素;ステアリルアルコール、セチルアルコール等のアルコール;ミリスチン酸、ラウリン酸、パルミチン酸等の脂肪酸;モノグリセライド、トリグリセライド等の合成油脂;シリコーン等が挙げられる。これらは、保湿成分としても含有することができる。
<高分子物質類(カチオン化ポリマーを除く)>
カルボキシメチルセルロースおよびその塩、ヒドロキシエチルセルロールおよびその塩、アルギン酸およびその塩、ポリリン酸およびその塩、ポリアクリル酸およびその塩、ピロリン酸およびその塩、結晶セルロース、アラビアゴム、キサンタンガム、グアーガム、ローカストビーンガム、ゼラチン、スチレン重合体エマルション、デキストリン、ポリエチレングリコール、流動パラフィン、カゼイン、ポリオキシエチレンポリオキシプロピレングリコール、モノステアリン酸ポリエチレングリコール等が挙げられる。上記高分子物質類の中でも、本発明の打錠剤を入浴剤とする場合には、流動パラフィン、デキストリン、ポリエチレングリコールを含有することが好ましく、これらは製剤助剤としても好適である。
<Inorganic salts (excluding sodium bicarbonate and sodium carbonate)>
Chloride such as sodium chloride, potassium chloride, ammonium chloride, sodium sesquicarbonate, calcium carbonate, potassium carbonate, magnesium carbonate, heavy magnesium carbonate, carbonate, sodium sulfate, magnesium sulfate, aluminum sulfate, iron sulfate, potassium aluminum sulfate , Sulfates such as sodium thiosulfate, calcium thiosulfate, potassium thiosulfate and sodium hyposulfite, nitrates such as sodium nitrate, potassium nitrate and calcium nitrate, phosphates such as sodium phosphate and calcium hydrogen phosphate, calcium silicate, Magnesium silicate, calcium sulfide, calcium disulfide, potassium sulfide, sodium sulfide, ammonium sulfide, barium sulfide, zinc sulfide, tin sulfide, antimony sulfide, iron sulfide, carbon disulfide, phosphorus sulfide, and other sulfides, sodium hydroxide , Hydroxides such as calcium hydroxide, borax, boric acid, calcium oxide, potassium bromide, and potassium permanganate and the like. Among the inorganic salts, sodium chloride, sodium sulfate, potassium aluminum sulfate, magnesium sulfate, calcium carbonate, and calcium silicate are preferable. In particular, when the tableted tablet of the present invention is used as a bath agent, sodium sulfate, silica It is preferable to contain calcium acid, and these are also suitable as formulation aids.
<Oil components>
Natural fats and oils such as nuka oil, jojoba oil, olive oil and soybean oil; hydrocarbons such as petrolatum, squalane and squalene; alcohols such as stearyl alcohol and cetyl alcohol; fatty acids such as myristic acid, lauric acid and palmitic acid; monoglycerides and triglycerides Synthetic oils and fats; silicone and the like. These can also be contained as a moisturizing component.
<High molecular substances (excluding cationized polymers)>
Carboxymethylcellulose and its salt, hydroxyethyl cellulose and its salt, alginic acid and its salt, polyphosphoric acid and its salt, polyacrylic acid and its salt, pyrophosphoric acid and its salt, crystalline cellulose, gum arabic, xanthan gum, guar gum, locust bean Examples include gum, gelatin, styrene polymer emulsion, dextrin, polyethylene glycol, liquid paraffin, casein, polyoxyethylene polyoxypropylene glycol, and polyethylene glycol monostearate. Among the above polymer substances, when the tablet of the present invention is used as a bath agent, it preferably contains liquid paraffin, dextrin and polyethylene glycol, and these are also suitable as formulation aids.
<香料成分・精油成分類>
ハッカ、ユーカリ、レモン、バーベナ、シトロネラ、カヤプテ、サルビア、タイム、クローブ、ローズマリー、ヒソップ、ジャスミン、カモミール、ネロリ、ヨモギ、ペリーラ、マジョラム、ローレル、ジュニパーベリー、ナツメグ、ジンジャー、オニオン、ガーリック、ラベンダー、ベルガモット、クラリーセージ、ペパーミント、バジル、ローズ、プチグレン、シナモン、メース、シトラール、シトロネラール、ボルネオール、リナロール、ゲラニオール、ネロール、ロジノール、オレンジ、アルテミシア、カンフル、メントール、シネオール、オイゲノール、ヒドロキシシトロネラール、サンダルウッド、コスタス、ラブダナム、アンバー、ムスク、α−ピネン、リモネン、サリチル酸メチル、ソウジュツ、ビャクジュツ、カノコソウ、ケイガイ、コウボク、センキュウ、トウヒ、トウキ、ショウキョウ、シャクヤク、オウバク、オウゴン、サンシン、ケイヒ、ニンジン、ブクリョウ、ドクカツ、ショウブ、ガイヨウ、マツブサ、ビャクシ、ジュウヤク、ウイキョウ、チンピ、カミツレ等の精油類、亜硝酸アミル、トリメチルシクロヘキサノール、アリルサルファイド、ノニルアルコール、デシルアルコール、フェニルエチルアルコール、炭酸メチル、炭酸エチル、フェニル酢酸エステル、グアイアコール、インドール、クレゾール、チオフェノール、p−ジクロロベンゼン、p−メチルキノリン、イソキノリン、ピリジン、アブシンス油酢酸、酢酸エステル等の「Perfume and Flavor Materials of Natural Origin」,Steffen Arctander,Allured Pub.Co.(1960)、「香りの百科」,日本香料協会編,朝倉書店(1989)、「Flower oils and Floral Compounds In Perfumery」,Danute Pajaujis Anonis,Allured Pub.Co.(1993)、「Perfume and Flavor Chemicals(aroma chemicals)」,Vols.I and II,Steffen Arctander,Allured Pub.Co.(1994)、「香料と調香の基礎知識」, 中島基貴編著,産業図書(1995)、「合成香料 化学と商品知識」,印藤元一著,化学工業日報社(1996)、「香りの百科事典」,谷田貝光克編,丸善(2005)に記載の香料成分や精油成分が挙げられる。これらの香料成分、精油成分は、1種単独で使用されても、また2種以上を任意に組み合わせて、調合香料として使用することもできる。さらに、溶剤、香料安定化剤等を適宜混合し、香料組成物として使用することもできる。
<Perfume ingredients and essential oil ingredients>
Peppermint, eucalyptus, lemon, verbena, citronella, kayapte, salvia, thyme, clove, rosemary, hyssop, jasmine, chamomile, neroli, mugwort, perilla, marjoram, laurel, juniper berry, nutmeg, ginger, onion, garlic, lavender, Bergamot, Clary Sage, Peppermint, Basil, Rose, Petit Glen, Cinnamon, Mace, Citral, Citronellal, Borneol, Linalool, Geraniol, Nerol, Rodinol, Orange, Artemisia, Camphor, Menthol, Cineol, Eugenol, Hydroxycitronellal, Sandalwood, Costas, Labdanum, Amber, Musk, α-Pinene, Limonene, Methyl salicylate, Sowjutsu, Sandalwood, Kanokosou Oil, such as pearl oysters, Japanese cypress, senkyu, spruce, spruce, ginger, peonies, peonies, gongos, sanshin, keihi, carrots, dragonflies, dough cutlet, ginger, ginger, pine bush, peony, jujube, fennel, chimney, chamomile Amyl nitrate, trimethylcyclohexanol, allyl sulfide, nonyl alcohol, decyl alcohol, phenylethyl alcohol, methyl carbonate, ethyl carbonate, phenylacetate, guaiacol, indole, cresol, thiophenol, p-dichlorobenzene, p-methylquinoline, isoquinoline "Perfume and Flavor Materials of Natural Origin", Steffe n Arctander, Allured Pub. Co. (1960), “Encyclopedia of Scents”, edited by Japan Fragrance Association, Asakura Shoten (1989), “Flowers oils and Floral Compounds In Perfumery”, Danute Pajaudis Anonis, Allred Pub. Co. (1993), “Perfume and Flavor Chemicals (aroma chemicals)”, Vols. I and II, Steffen Arctander, Allured Pub. Co. (1994), “Fundamentals of perfumes and fragrances”, edited by Motoki Nakajima, Sangyo Tosho (1995), “Synthetic perfumes Chemistry and product knowledge”, Motokazu Into, Kagaku Kogyo Nipposha (1996), “Encyclopedia of Scents” Examples include fragrance components and essential oil components described in “Encyclopedia”, Mitsatsu Yatakai, Maruzen (2005). These fragrance components and essential oil components can be used alone or in combination of two or more types as a blended fragrance. Furthermore, a solvent, a fragrance | flavor stabilizer, etc. can be mixed suitably and can also be used as a fragrance | flavor composition.
<生薬類>
カミツレ、ガイヨウ、カンピ、ウイキョウ、ケイガイ、ケイヒ、ショウキョウ、チンピ、センキュウ、ショウブ、トウキ、トウヒ、ドクダミ、トウガラシ、シラカバ、ゴボウ、ニンジン、ニンニク、チョウジ、ローズマリー、ユズ、タイム等が挙げられる。これらは抽出液として含有しても良い。また、香料もしくは保湿成分としても含有することができる。
<酵素類>
トリプシン、α−キモトリプシン、ブロメライン、パパイン、プロテアーゼ、プロクターゼ、セラチオペプチダーゼ、リゾチーム、ペプシン等が挙げられる。
<顔料・鉱物類>
酸化チタン、タルク、クレー、カオリン、ベンガラ、黄酸化鉄、マイカ、雲母、チタン、二酸化チタン、酸化亜鉛、ベントナイト、ゼオライト、無水ケイ酸、メタケイ酸、中性白土等、これらの被覆粒(顆粒)等が挙げられる。上記顔料・鉱物類の中でも、本発明の打錠剤を入浴剤とする場合には、酸化チタンを含有することが好ましく、これは製剤助剤としても好適である。
<色素類>
青色1号、青色2号、赤色102号、赤色106号、赤色227号、赤色230号の(1)、黄色4号、黄色5号、黄色202号の(1)、緑色3号、緑色201号、緑色204号、橙色205号等の法定色素、クロロフィル、リボフラビン、アンナット、アントシアニン等の天然色素等が挙げられる。
<ビタミン類およびその誘導体>
ビタミンA、ビタミンB、ビタミンC、ビタミンD、ビタミンE、ビタミンF、ビタミンH、パントテン酸、ニコチン酸又はその誘導体、ビタミンEニコチン酸エステル、酢酸トコフェロール、アスコルビン酸ナトリウム等が挙げられる。これらは、保湿成分としても含有することができる。
<Herbal medicines>
Examples include chamomile, gailla, campi, fennel, kei-gai, keihi, gyoza, chimpi, senkyu, shobu, tokyo, spruce, dokudami, capsicum, birch, burdock, carrot, garlic, clove, rosemary, yuzu and thyme. These may be contained as an extract. Moreover, it can contain as a fragrance | flavor or a moisturizing component.
<Enzymes>
Examples include trypsin, α-chymotrypsin, bromelain, papain, protease, proctase, seratiothiopeptidase, lysozyme, and pepsin.
<Pigments and minerals>
Titanium oxide, talc, clay, kaolin, bengara, yellow iron oxide, mica, mica, titanium, titanium dioxide, zinc oxide, bentonite, zeolite, silicic anhydride, metasilicic acid, neutral clay, etc. Etc. Among the pigments and minerals, when the tableted tablet of the present invention is used as a bath agent, it is preferable to contain titanium oxide, which is also suitable as a formulation aid.
<Dyes>
Blue No. 1, Blue No. 2, Red No. 102, Red No. 106, Red No. 227, Red No. 230 (1), Yellow No. 4, Yellow No. 5, Yellow No. 202 (1), Green No. 3, Green No. 201 No., legal dyes such as green No. 204 and orange No. 205, and natural dyes such as chlorophyll, riboflavin, annatto and anthocyanin.
<Vitamins and their derivatives>
Vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin F, vitamin H, pantothenic acid, nicotinic acid or derivatives thereof, vitamin E nicotinate, tocopherol acetate, sodium ascorbate and the like can be mentioned. These can also be contained as a moisturizing component.
<海藻抽出物類>
アナアオサ、ミル、ウスバアオノリ、ヒトエグサ、スジアオノリ、カサノリ、ヘライワヅタ、ハネモ、ナガミル等の緑藻植物、ウミウチワ、アミジグサ、モズク、イロロ、マツモ、イワヒゲ、ハバノリ、ウルシグサ、カジメ、マコンブ、ワカメ、トロロコンブ、ヒジキ、アラメ、ホンダワラ、ウミトラノオ等の褐藻植物、マルバアマノリ、アサクサノリ、スサビノリ、ウミゾウメン、ヒラクサ、マクサ、トリアシ、ハナフノリ、フクロフノリ、トサカノリ、トゲキリンサイ、アカバギンナンソウ、コトジツノマタ、ツノマタ、アヤニシキ、マクリ、エゴノリ、オゴノリ、イバラノリ等の紅藻植物等から得られる抽出物等が挙げられる。これらは、保湿成分としても含有することができる。
<植物抽出物類>
アロエ抽出物、緑茶抽出物、ヘチマ水、カモミラエキス、カンゾウエキス、コンフリーエキス、ユーカリエキス、ローヤルゼリーエキス、レモン抽出液、ローズヒップ抽出液、モモの葉エキス等が挙げられる。抽出方法に特に制限はない。これらは、保湿成分としても含有することができる。
<冷感物質類>
メントール、カンフル、チモール等のメントール誘導体、単環式化合物、二環式アルコール、三環式アルコール、三環式アミド、ハッカ油等が挙げられる。
<保湿成分類>
セラミド、セラミド誘導体、セラミド類似物質などのセラミド類等;乳酸ナトリウム、酒石酸二ナトリウム、ピロリドンカルボン酸ナトリウム、グルタミン酸二ナトリウム等の有機酸塩類;イソプレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリン、キシロース、キシリトール、ソルビトール等の多価アルコール類;ポリビニルアルコール、アルギン酸ナトリウム、ポリビニルピロリドン等の水溶性高分子類、コンドロイチン硫酸、ヒアルロン酸等のムコ多糖類、コラーゲンやその誘導体、蛋白質、ケラチン、フィブロインおよびその加水分解物;ミリスチン酸イソプロピル、パルミチン酸イソプロピル等の脂肪酸エステル類、シア脂、スクワラン、プラセンタ、アルブチン、カゼイン、シルク、はちみつ等が挙げられる。
<Seaweed extracts>
Anaaaosa, Mill, Usbaaonori, Hitegusa, Susiaoonori, Casanori, Green Algae Plants such as Heraiwata, Hanemomo, Nagarami, etc. Brown algae plants such as Honda walla, Umitorano, Marubaamanori, Asakusanori, Susabinori, Cyprinus, Hirakusa, Macausa, Triashi, Hanafnori, Owl, Nori, Tosekirinsai, Akagiginanso, Nigiri nori, Nigiri norii Extracts obtained from red algae plants and the like. These can also be contained as a moisturizing component.
<Plant extracts>
Examples include aloe extract, green tea extract, loofah water, chamomile extract, licorice extract, comfrey extract, eucalyptus extract, royal jelly extract, lemon extract, rosehip extract, peach leaf extract and the like. There is no particular limitation on the extraction method. These can also be contained as a moisturizing component.
<Cool sensations>
Mentor derivatives such as menthol, camphor and thymol, monocyclic compounds, bicyclic alcohols, tricyclic alcohols, tricyclic amides, mint oil and the like.
<Moisturizing ingredients>
Ceramides such as ceramide, ceramide derivatives and ceramide-like substances; organic acid salts such as sodium lactate, disodium tartrate, sodium pyrrolidonecarboxylate, disodium glutamate; isoprene glycol, propylene glycol, 1,3-butylene glycol, glycerin, Polyhydric alcohols such as xylose, xylitol, sorbitol; water-soluble polymers such as polyvinyl alcohol, sodium alginate, polyvinylpyrrolidone, mucopolysaccharides such as chondroitin sulfate and hyaluronic acid, collagen and derivatives thereof, protein, keratin, fibroin and Hydrolyzate: Fatty acid esters such as isopropyl myristate and isopropyl palmitate, shea butter, squalane, placenta, arbutin, casein, silk, honey, etc. And the like.
<溶剤>
精製水、イオン交換水、エタノール、プロパノール、ベンジルアルコール等のアルコール、エチレングリコール、ジエチレングリコール、ジプロピレングリコール、グリセリン、1,3−ブタンジオール等の多価アルコール、エチレングリコールモノメチルエーテル、エチレングリコールモノエチルエーテル、エチレングリコールモノプロピルエーテル、エチレングリコールモノブチルエーテル、ジエチレングリコールモノメチルエーテル、ジエチレングリコールモノエチルエーテル、ジエチレングリコールモノプロピルエーテル、ジエチレングリコールモノブチルエーテル、ジエチレングリコールモノイソブチルエーテル、トリエチレングリコールモノブチルエーテル、プロピレングリコールモノメチルエーテル、プロピレングリコールジメチルエーテル、ジプロピレングリコールモノメチルエーテル、トリプロピレングリコールモノメチルエーテル、トリプロピレングリコールモノブチルエーテル、プロピレングリコールモノプロピルエーテル、ジプロピレングリコールモノプロピルエーテル、プロピレングリコールモノブチルエーテル、プロピレングリコール−tert−ブチルエーテル、ジプロピレングリコールモノブチルエーテル、ジプロピレングリコールジメチルエーテル、フェニルカルビトール、フェニルセロソルブ、ベンジルカルビトール等のグリコールエーテル類、n−パラフィン等のパラフィン類、ジエチルフタレート、ベンジルベンゾエート、トリエチルシトレート、ミリスチン酸イソプロピル等のエステル類、その他3−メチル−4−メトキシブタノール、N−メチルピロリドン、炭酸プロピレン等が挙げられる。
<界面活性剤>
ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンポリオキシプロピレン共重合体、ポリオキシエチレン脂肪酸エステル、ソルビタン脂肪酸エステル等の非イオン系活性剤;石けん用素地などの脂肪酸エステル、α−オレフィンスルホン酸ナトリウム、ラウリル硫酸ナトリウム、ポリオキシエチレンラウリル硫酸ナトリウム、ヤシ油脂肪酸メチルタウリンナトリウム等の陰イオン系活性剤;アルキルベタイン、アルキルアミドプロピルベタイン、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン等の両性界面活性剤;アルキルアミン塩、第四級アンモニウム塩等の陽イオン性界面活性剤等が挙げられる。
<Solvent>
Purified water, ion-exchanged water, alcohols such as ethanol, propanol and benzyl alcohol, polyhydric alcohols such as ethylene glycol, diethylene glycol, dipropylene glycol, glycerin and 1,3-butanediol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether , Ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monopropyl ether, diethylene glycol monobutyl ether, diethylene glycol monoisobutyl ether, triethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol di Chill ether, dipropylene glycol monomethyl ether, tripropylene glycol monomethyl ether, tripropylene glycol monobutyl ether, propylene glycol monopropyl ether, dipropylene glycol monopropyl ether, propylene glycol monobutyl ether, propylene glycol-tert-butyl ether, dipropylene glycol monobutyl ether , Glycol ethers such as dipropylene glycol dimethyl ether, phenyl carbitol, phenyl cellosolve, benzyl carbitol, paraffins such as n-paraffin, esters such as diethyl phthalate, benzyl benzoate, triethyl citrate, isopropyl myristate, etc. 3 -Methyl-4-methoxybutanol N- methylpyrrolidone and propylene carbonate.
<Surfactant>
Nonionic active agents such as polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene copolymer, polyoxyethylene fatty acid ester, sorbitan fatty acid ester; fatty acid ester such as soap base, α- Anionic active agents such as sodium olefin sulfonate, sodium lauryl sulfate, sodium polyoxyethylene lauryl sulfate, sodium coconut oil fatty acid methyl taurine; alkyl betaine, alkylamidopropyl betaine, 2-alkyl-N-carboxymethyl-N-hydroxy Examples include amphoteric surfactants such as ethyl imidazolinium betaine; cationic surfactants such as alkylamine salts and quaternary ammonium salts.
<退色防止剤>
グリシン、アラニン、グルタミン酸などのアミノ酸;サリチル酸およびその塩等が挙げられる。
<pH調整剤>
リン酸水素二ナトリウム、リン酸三ナトリウム、クエン酸水素二ナトリウム、クエン酸三ナトリウム等が挙げられる。
<殺菌剤>
イソプロピルメチルフェノール、トリクロサン、ジクロロイソシアヌル酸、銀ゼオライト、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼントニウム、塩化クロルヘキシジン、ヒノキチオール、フェノール、グリチルリチン酸塩およびその誘導体等が挙げられる。
<その他>
ブドウ糖、ショ糖、トレハロース、フィトコラージュ、イソフラボン、パラオキシ安息香酸エステル、野菜または果物抽出物(エキス)、海洋深層水等が挙げられる。
上述した任意成分の含有量は、本発明の効果を損なわない範囲で適宜設定すればよい。また、用途及び必要に応じて本発明の打錠剤は、公知の水溶性フィルム等で覆ってもよい。
<Anti-fading agent>
Examples include amino acids such as glycine, alanine, and glutamic acid; salicylic acid and salts thereof.
<PH adjuster>
Examples thereof include disodium hydrogen phosphate, trisodium phosphate, disodium hydrogen citrate, and trisodium citrate.
<Fungicide>
Examples include isopropylmethylphenol, triclosan, dichloroisocyanuric acid, silver zeolite, cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, chlorhexidine chloride, hinokitiol, phenol, glycyrrhizinate and derivatives thereof.
<Others>
Examples thereof include glucose, sucrose, trehalose, phytocollage, isoflavone, paraoxybenzoic acid ester, vegetable or fruit extract (extract), deep sea water and the like.
What is necessary is just to set content of the arbitrary component mentioned above suitably in the range which does not impair the effect of this invention. Moreover, you may cover the tableting of this invention with a well-known water-soluble film etc. as needed and needed.
以下に実施例において本発明を具体的に説明するが、本発明は、これらの実施例に限定されるものではない。 EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to these examples.
<参考試験>
[試験検体]
炭酸水素ナトリウム、炭酸ナトリウム、コハク酸、カチオン化セルロースを含有する直径50mm、厚さ約15mm、全量45gの約98kN(約10t)の圧力で打錠した円柱状打錠剤を、試験検体Aとした。
また、試験検体Aとカチオン化セルロースを含有しない点でのみ相違する円柱状打錠剤を、試験検体aとした。
[試験検体の評価]
試験検体A、aの天面中心部に圧力がかかるように、デジタルフォースゲージ(アイコーエンジニアリング株式会社製、計測用のアタッチメント:押圧部、直径15mmの円形)を用いて、側面(厚み)方向に対して圧力をかけていき、亀裂やひびが生じたときの最大圧力を打錠硬度とした。評価試験は3回行い、その平均値をそれぞれの打錠硬度とした。
試験検体aの打錠硬度は5.4kgfであるのに対し、試験検体Aの打錠硬度は2.0kgfであった。
<Reference test>
[Test sample]
A test sample A was a columnar tablet containing sodium bicarbonate, sodium carbonate, succinic acid, cationized cellulose and having a diameter of 50 mm, a thickness of about 15 mm, and a total amount of 45 g and compressed at a pressure of about 98 kN (about 10 t). .
A cylindrical tablet that differs only in that it does not contain test sample A and cationized cellulose was designated as test sample a.
[Test specimen evaluation]
Using a digital force gauge (manufactured by Aiko Engineering Co., Ltd., measurement attachment: pressing part, circle with a diameter of 15 mm) in the side surface (thickness) direction so that pressure is applied to the center of the top surface of the test specimens A and a. On the other hand, pressure was applied, and the maximum pressure when cracks or cracks occurred was defined as tableting hardness. The evaluation test was performed three times, and the average value was defined as each tableting hardness.
The tableting hardness of test specimen a was 5.4 kgf, while the tableting hardness of test specimen A was 2.0 kgf.
上記「参考試験」の結果より、カチオン化セルロース等のカチオン化ポリマーを配合することにより、打錠剤の打錠硬度が4割程度にまで低下することが明らかとなった。上記打錠条件における打錠硬度が2.0kgf程度では、製造時、保管時および輸送時等に破損が予想されるため、打錠硬度を向上させる必要があった。
炭酸水素ナトリウム、炭酸ナトリウム、コハク酸、カチオン化セルロースそれぞれを検討した結果、主要配合成分である炭酸水素ナトリウムを変更することにより、打錠剤の打錠硬度が変化するという新たな知見を得たので、炭酸水素ナトリウムについて詳細な検討を行った。
From the results of the above “reference test”, it has been clarified that the tableting hardness of the tableting is reduced to about 40% by adding a cationized polymer such as cationized cellulose. When the tableting hardness under the above tableting conditions is about 2.0 kgf, the tableting hardness needs to be improved because damage is expected at the time of manufacture, storage and transportation.
As a result of examining each of sodium hydrogen carbonate, sodium carbonate, succinic acid, and cationized cellulose, we obtained new knowledge that the tableting hardness of the tablet changes by changing sodium bicarbonate, which is the main compounding ingredient. A detailed study was conducted on sodium bicarbonate.
<炭酸水素ナトリウムに関する詳細検討試験>
[試験検体の作製]
市販されている炭酸水素ナトリウムおよび、それを篩による分級または破砕することにより7種類の炭酸水素ナトリウムを得、これを試験検体1〜7とした。試験検体1〜7の平均粒子径はいずれも150μmより大きかった。
[試験検体の評価]
打錠硬度は、上述の15g打錠剤での打錠硬度測定方法に従い炭酸水素ナトリウムのみの打錠剤の硬度を測定した。
また、上述の測定方法に従い「a線とb線との比(a線/b線)の平均」、「かさ比重」、「圧縮率」を算出した。
さらに、試験検体の顕微鏡による観察画像を解析することにより、「a線とb線との比(a線/b線)の平均」が2以上4以下の結晶が炭酸水素ナトリウム全量に対して含まれる割合を計測した。
評価結果を表1に示す。
<Detailed study on sodium bicarbonate>
[Preparation of test specimen]
Seven types of sodium bicarbonate were obtained by classifying or crushing commercially available sodium bicarbonate and sieving it with sieves, and these were designated as test samples 1-7. The average particle diameters of the test samples 1 to 7 were all larger than 150 μm.
[Test specimen evaluation]
The tableting hardness was determined by measuring the hardness of a tablet made of only sodium hydrogen carbonate in accordance with the above-mentioned tableting hardness measurement method for 15 g tableting.
Further, according to the measurement method described above, “average ratio of a line to b line (a line / b line)”, “bulk specific gravity”, and “compression ratio” were calculated.
Furthermore, by analyzing the microscope observation image of the test specimen, a crystal having an “ratio of a line to b line (a line / b line)” of 2 or more and 4 or less is included in the total amount of sodium bicarbonate. The ratio of being measured was measured.
The evaluation results are shown in Table 1.
表1に示すとおり、全く意外にも、炭酸水素ナトリウムは、その形状等により打錠硬度が大きく変化するという新たな知見を、本発明者は見出した。
詳細に検討すると、打錠硬度が大きく向上する炭酸水素ナトリウムは、「a線とb線との比(a線/b線)の平均が2以上4以下であり、かつ、かさ比重が1.05g/mL以下」の要件を満たすことが確認され、表1中では、試験検体1〜3の炭酸水素ナトリウムが該当することも明らかにした。
これに対し、a線とb線との比(a線/b線)の平均が2.0であるものの、かさ比重が本発明の範囲外である試験検体4の炭酸水素ナトリウムは、その打錠硬度が2.5kgfであり、試験検体1〜3の炭酸水素ナトリウムの打錠硬度に比べて、大きく劣ることが明らかとなった。
さらに、かさ比重が1.03g/mLであるものの、a線とb線との比(a線/b線)の平均が1.7である試験検体5の炭酸水素ナトリウムは、その打錠硬度が1.2kgfであり、試験検体1〜3の炭酸水素ナトリウムの打錠硬度に比べて、大きく劣ることも明らかとなった。
As shown in Table 1, the present inventors have surprisingly found a new finding that the tableting hardness of sodium bicarbonate varies greatly depending on its shape and the like.
When examined in detail, sodium hydrogen carbonate whose tableting hardness is greatly improved is that the average of the ratio of a line to b line (a line / b line) is 2 or more and 4 or less and the bulk specific gravity is 1. It was confirmed that the requirement of “05 g / mL or less” was satisfied, and in Table 1, it was also clarified that the sodium hydrogen carbonates of the test samples 1 to 3 corresponded.
On the other hand, although the average of the ratio of a line to b line (a line / b line) is 2.0, sodium bicarbonate of test specimen 4 whose bulk specific gravity is outside the scope of the present invention is The tablet hardness was 2.5 kgf, which was clearly inferior to the tableting hardness of sodium bicarbonate of Test Samples 1 to 3.
Further, although the bulk specific gravity is 1.03 g / mL, the sodium bicarbonate of the test sample 5 whose average of the ratio of the a line and the b line (a line / b line) is 1.7 is the tableting hardness. Was 1.2 kgf, which was also found to be significantly inferior to the tableting hardness of sodium bicarbonate of Test Samples 1 to 3.
<打錠剤の打錠硬度確認試験>
<実施例1〜3、比較例1〜4、参考例1、2>
[試験検体の作製]
上記「炭酸水素ナトリウムに関する詳細検討試験」の試験検体1〜7の炭酸水素ナトリウムをそれぞれ使用して、表2に記載の配合量(表2中の数字は重量%を意味している。)を均一に混合し、粉末混合物を得た。この粉末混合物を、油圧ポンプ式打錠機を用いて25kNの圧力で圧縮成形し、直径30mm×厚さ概略15mmの15gの打錠剤を作製した。得られた打錠剤の打錠硬度は、上述の15g打錠剤での打錠硬度測定方法に従い測定した。使用した炭酸ナトリウムの平均粒子径は300μmであった。実施例1〜3、比較例1〜4、参考例1、2の打錠剤の配合量と、それぞれの打錠硬度をまとめて、表2に示す。
<Tablet hardness confirmation test for tablets>
<Examples 1-3, Comparative Examples 1-4, Reference Examples 1 and 2>
[Preparation of test specimen]
Using the sodium bicarbonates of test specimens 1 to 7 in the above-mentioned “detailed examination test on sodium bicarbonate”, the blending amounts shown in Table 2 (the numbers in Table 2 mean weight%). Mixing uniformly gave a powder mixture. This powder mixture was compression-molded at a pressure of 25 kN using a hydraulic pump type tableting machine to produce 15 g of a tablet having a diameter of 30 mm and a thickness of approximately 15 mm. The tableting hardness of the resulting tableting tablet was measured according to the tableting hardness measurement method for the 15-g tableting tablet described above. The average particle size of the sodium carbonate used was 300 μm. Table 2 summarizes the blending amounts of each of Examples 1 to 3, Comparative Examples 1 to 4, and Reference Examples 1 and 2 and the tableting hardness.
表2の結果より、炭酸水素ナトリウム単独での打錠剤において、打錠硬度の向上が確認された試験検体1〜3の炭酸水素ナトリウムは、カチオン化セルロースを含有する打錠剤に配合することにより、打錠剤としての打錠硬度をも向上し得ることが明らかとなった。
カチオン化セルロースを含有する打錠剤(実施例1〜3、比較例1〜4)は、カチオン化セルロースを含有しない打錠剤(参考例1、2)に比べて打錠硬度が低下する。しかしながら、実施例2と参考例1、比較例4と参考例2との比較より、実施例2の打錠剤は、その打錠硬度の低下が抑制されていることが理解できる。
これらの結果より、特定の炭酸水素ナトリウムを配合することにより、カチオン化セルロースを含有する打錠剤においても、打錠硬度を2kgf以上、より好ましくは2.5kgf以上、より好ましくは3kgf以上とし得ることが確認された。
From the results of Table 2, in tableting with sodium bicarbonate alone, sodium bicarbonate of Test Samples 1 to 3 in which improvement in tableting hardness was confirmed was blended with tableting containing cationized cellulose. It has been clarified that the tableting hardness as a tableting tablet can be improved.
Tableting hardness containing cationized cellulose (Examples 1 to 3 and Comparative Examples 1 to 4) has lower tableting hardness than tableting tablets not containing cationized cellulose (Reference Examples 1 and 2). However, it can be understood from the comparison between Example 2 and Reference Example 1 and Comparative Example 4 and Reference Example 2 that the tableting hardness of Example 2 is suppressed from decreasing in tableting hardness.
From these results, the tableting hardness containing cationized cellulose can be set to 2 kgf or more, more preferably 2.5 kgf or more, more preferably 3 kgf or more by blending with specific sodium hydrogen carbonate. Was confirmed.
<空隙面積と空隙率の確認試験>
[空隙面積(150倍率)の測定方法]
上記「打錠剤の打錠硬度確認試験」において作製した打錠剤(実施例1〜3、比較例1〜4)を試験検体として使用した。
各試験検体の直径部で概略2分割し、その断面を、走査型電子顕微鏡(SEM:Scanning Electron Microscope)により150倍の倍率で観察した。当該断面の画像における、原料由来の固体相と気泡相(空隙部)とを2値化して画像処理により気泡相面積を測定し、空隙面積(150倍率)とした。
[実空隙面積の算出方法]
上記150倍の倍率で測定した空隙面積(150倍率)を、倍率を1倍とした実空隙面積への換算を、下記算出式により行った。
<算出式>
実空隙面積(mm2)=空隙面積(150倍率)÷(150×150)
[空隙率の算出方法]
画像処理した全面積に対し、空隙面積(150倍率)の割合を算出した。
<算出式>
空隙率(%)=(空隙面積(150倍率)÷処理画像の面積)×100
なお、算出式の「処理画像の面積」は、上記「空隙面積(150倍率)の測定方法」における断面画像の面積を意味する。処理画像は、1280ピクセル×960.05ピクセルであり、解像度は201dpi(dots per inch)であった。1インチは25.4mmであるから、1280ピクセルは161.75mmに相当(25.4÷201×1280≒161.75)し、960.05ピクセルは121.32mm(25.4÷201×960.05≒121.32)に相当する。すなわち、処理画像の面積は、19623.51mm2(161.75×121.32)として各試験検体の空隙率(%)を算出した。
実施例1〜3、比較例1〜4の打錠剤の空隙面積(150倍率)(mm2)、実空隙面積(mm2)、空隙率(%)をまとめて、表3に示す。
<Verification test of void area and porosity>
[Measurement method of void area (150 times magnification)]
The tableting (Examples 1 to 3 and Comparative Examples 1 to 4) prepared in the above “Tabletting hardness confirmation test of tableting” was used as a test specimen.
Each test specimen was roughly divided into two parts at the diameter, and the cross section was observed with a scanning electron microscope (SEM) at a magnification of 150 times. In the image of the cross section, the solid phase derived from the raw material and the bubble phase (void portion) were binarized, and the bubble phase area was measured by image processing to obtain a void area (150 magnifications).
[Calculation method of actual void area]
The void area measured at a magnification of 150 times (150 magnification) was converted into an actual void area with a magnification of 1 by the following calculation formula.
<Calculation formula>
Actual void area (mm 2 ) = void area (150 magnification) ÷ (150 × 150)
[Calculation method of porosity]
The ratio of the void area (150 magnification) was calculated with respect to the total area subjected to image processing.
<Calculation formula>
Void ratio (%) = (Cavity area (150 magnification) ÷ Processed image area) × 100
The “area of the processed image” in the calculation formula means the area of the cross-sectional image in the “method for measuring the void area (150 magnification)”. The processed image was 1280 pixels × 960.05 pixels, and the resolution was 201 dpi (dots per inch). Since 1 inch is 25.4 mm, 1280 pixels corresponds to 161.75 mm (25.4 ÷ 201 × 1280≈161.75), and 960.05 pixels are 121.32 mm (25.4 ÷ 201 × 960. 05≈121.32). That is, the void ratio (%) of each test specimen was calculated assuming that the area of the processed image was 19623.51 mm 2 (161.75 × 121.32).
Table 3 shows the void area (150 magnification) (mm 2 ), actual void area (mm 2 ), and void ratio (%) of the compressed tablets of Examples 1 to 3 and Comparative Examples 1 to 4.
表3の結果より、実施例1〜3の打錠剤は、比較例1〜4の打錠剤に比べて、空隙面積、空隙率ともに大きく低下することが確認された。 From the results of Table 3, it was confirmed that the tableting examples of Examples 1 to 3 were greatly reduced in both the void area and the porosity as compared with the tableting of Comparative Examples 1 to 4.
<打錠剤の吸液時間確認試験>
[試験詳細]
上記「打錠剤の打錠硬度確認試験」において作製した打錠剤(実施例1〜3、比較例1〜4、参考例1、2)を試験検体として使用し、上述の吸液時間A測定方法に従い、吸液時間Aを測定した。また、測定前後の試験検体の重量差より、吸液量(g)を算出した。 実施例1〜3、比較例1〜4、参考例1、2の打錠剤の吸液時間A(分)と吸液量(g)をまとめて、表4に示す。
<Tablet absorption time confirmation test>
[Examination details]
The above-described liquid absorption time A measuring method using the tableting (Examples 1 to 3, Comparative Examples 1 to 4, Reference Examples 1 and 2) prepared in the above “Tabletting hardness confirmation test for tablets” as a test specimen In accordance with this, the liquid absorption time A was measured. Moreover, the liquid absorption amount (g) was calculated from the weight difference between the test specimens before and after the measurement. Table 4 shows the liquid absorption time A (minute) and liquid absorption amount (g) of the tableted tablets of Examples 1 to 3, Comparative Examples 1 to 4, and Reference Examples 1 and 2.
表4の結果より、打錠硬度が2kgf以上の実施例1〜3の打錠剤は、吸液時間Aが45分以上65分以下の範囲であり、打錠硬度が2kgfより小さい比較例1〜4の打錠剤の吸液時間Aと比べて、10分またはそれ以上長い、すなわち、吸液速度がゆっくりであることが、また、打錠硬度が同程度である参考例2の吸液時間Aと比べて、10分またはそれ以上短い、すなわち、吸液速度が速いことが明らかとなった。
表3に示すとおり、実施例1〜3の打錠剤は、比較例1〜4の打錠剤に比べて、空隙面積、空隙率ともにかなり小さいことが確認されており、打錠硬度が高い実施例1〜3の入浴剤は、内部の空隙部分が少なく液体が浸透するのに時間を要するため、上記吸液時間Aは、比較例1〜4の打錠剤に比べて長くなると推測された。表4に示すとおり、実施例1〜3と比較例1〜4の打錠硬度と吸液時間Aとの関係性は、推測とおりの結果であることが明らかとなった。
一方、実施例1〜3と比較例1〜4の吸液量は、空隙率が大きく相違するにも関わらず、1.2〜1.3とほぼ同じであることが、さらに、参考例1、2の吸液量は25%程度低下することが明らかとなった。
打錠硬度が高い実施例1〜3の打錠剤は、比較例1〜4の打錠剤に比べて、内部の空隙部分が少ないため吸液量も減ると考えられるが、実施例1〜3と比較例1〜4における打錠硬度と吸液量との関係は、表4に示すとおり、予想に反する全く意外な結果であることが確認された。
本発明者は、実施例1〜3と比較例1〜4の吸液量がほぼ同じであることに着目し、次に打錠剤の崩壊性に関する評価試験を行った。
From the results in Table 4, the tableting hardness of Examples 1 to 3 having a tableting hardness of 2 kgf or more has a liquid absorption time A in the range of 45 minutes to 65 minutes, and the tableting hardness of Comparative Examples 1 to 2 is less than 2 kgf. The liquid absorption time A of Reference Example 2 is 10 minutes or more longer than the liquid absorption time A of 4 tableting tablets, that is, the liquid absorption speed is slow, and the tableting hardness is comparable. It was revealed that it was shorter than 10 minutes or more, that is, the liquid absorption speed was high.
As shown in Table 3, it was confirmed that the tableting examples of Examples 1 to 3 were considerably smaller in both void area and porosity than the tableting tablets of Comparative Examples 1 to 4, and the tableting hardness was high. Since the bathing agents 1 to 3 have a small internal void and require time for the liquid to penetrate, the liquid absorption time A was estimated to be longer than the tableting of Comparative Examples 1 to 4. As shown in Table 4, it was clarified that the relationship between the tableting hardness of Examples 1 to 3 and Comparative Examples 1 to 4 and the liquid absorption time A was as expected.
On the other hand, the liquid absorption amounts of Examples 1 to 3 and Comparative Examples 1 to 4 are substantially the same as 1.2 to 1.3 although the porosity is greatly different. It was revealed that the liquid absorption amount of No. 2 decreased by about 25%.
Although the tableting hardness of Examples 1 to 3 having high tableting hardness is considered to be reduced in the amount of liquid absorption due to a smaller internal void portion than the tableting tablets of Comparative Examples 1 to 4, As shown in Table 4, it was confirmed that the relationship between the tableting hardness and the liquid absorption amount in Comparative Examples 1 to 4 was a completely unexpected result contrary to expectations.
The inventor paid attention to the fact that the liquid absorption amounts of Examples 1 to 3 and Comparative Examples 1 to 4 were almost the same, and then performed an evaluation test on the disintegration property of the tableting.
<打錠剤の崩壊性確認試験>
[試験詳細]
上記「打錠剤の打錠硬度確認試験」において作製した打錠剤(実施例1〜3、比較例1〜4、参考例1、2)を試験検体として使用した。40℃/5Lの湯に各試験検体1錠を投入し、1錠が崩壊し完全に溶解するまでの時間(秒)を測定した。
実施例1〜3、比較例1〜4、参考例1、2の打錠剤の崩壊・溶解時間(秒)をまとめて、表5に示す。
<Tablet disintegration confirmation test>
[Examination details]
The tableting (Examples 1 to 3, Comparative Examples 1 to 4, Reference Examples 1 and 2) prepared in the above-mentioned “Tabletting hardness confirmation test of tableting” was used as a test specimen. One tablet of each test specimen was put into 40 ° C./5 L hot water, and the time (seconds) until one tablet disintegrated and completely dissolved was measured.
Table 5 summarizes the disintegration / dissolution times (seconds) of the compressed tablets of Examples 1 to 3, Comparative Examples 1 to 4, and Reference Examples 1 and 2.
表5の結果より、実施例1〜3の打錠剤は、比較例1〜4の打錠剤に比べて打錠硬度が高く、空隙率(%)が低いにも関わらず、湯に投入し完全に溶解するまでの時間が概略同程度であり、崩壊性に優れることが明らかとなった。
打錠剤については、打錠硬度が高いと水中に投入した際の錠剤崩壊性が悪化し、発生した炭酸ガスが効率よく水中に溶解させられないことが知られている。しかしながら、全く意外にも、本発明の打錠剤は、製造時、保管時および輸送時等に破損が発生しない良好な打錠硬度を保持しつつ、極めて良好な錠剤崩壊性が得られ、発生する炭酸ガスを効率よく水中に溶解させることができることが確認された。
From the results shown in Table 5, the tableting tablets of Examples 1 to 3 are completely poured into hot water despite the fact that the tableting hardness is higher than that of Comparative Examples 1 to 4 and the porosity (%) is low. It was clarified that the time until dissolution was approximately the same and the disintegration was excellent.
With regard to tableting, it is known that if the tableting hardness is high, the disintegration property of the tablet when it is put into water deteriorates, and the generated carbon dioxide gas cannot be efficiently dissolved in water. However, surprisingly, the tableting of the present invention can be obtained with a very good tablet disintegrating property while maintaining a good tableting hardness that does not cause breakage during production, storage and transportation. It was confirmed that carbon dioxide gas can be efficiently dissolved in water.
以上のとおり、本発明の打錠剤は、亀裂や割れ等の破損が生じることがなく優れた保形性を発揮するのみならず、この優れた保形性により、空気との接触面を最低限に抑制できるため、保存安定性をも向上するなど、製剤安定性に極めて優れている。しかも、本発明の打錠剤は、打錠硬度が高いにも関わらず、良好な錠剤崩壊性が得られ、発生する炭酸ガスを効率よく水中に溶解させることができる。
すなわち、本発明の打錠剤は、良好な製剤安定性と崩壊性の両立が図られており、極めて有用である。
As described above, the tableting of the present invention not only exhibits excellent shape retention without breakage such as cracks and cracks, but also has excellent shape retention so that the contact surface with air is minimized. Therefore, it is extremely excellent in formulation stability, such as improving storage stability. Moreover, although the tableting of the present invention has high tableting hardness, good tablet disintegration can be obtained, and the generated carbon dioxide gas can be efficiently dissolved in water.
That is, the tableted tablet of the present invention is very useful because it has both good formulation stability and disintegration.
Claims (4)
吸液時間A:環境温度25℃において、流動パラフィン5mlを入れた直径90mmのシャーレーに、直径30mm、全量15gの円柱状打錠剤の、円形の天面と底面が流動パラフィンの液面に対して垂直となるように載置してから、流動パラフィンが打錠剤の最頂点に到達するまでの時間 A tableting composition comprising sodium bicarbonate, sodium carbonate, an organic acid, a cationized polymer, having a tableting hardness of 2 kgf or more, and a liquid absorption time A of 45 minutes to 65 minutes.
Liquid absorption time A: At an environmental temperature of 25 ° C., a circular shaped tablet with a diameter of 30 mm and a total amount of 15 g in a 90 mm diameter petri dish containing 5 ml of liquid paraffin, and the top and bottom surfaces of the circle with respect to the liquid paraffin liquid level Time from placing the liquid paraffin vertically until the liquid paraffin reaches the top of the tablet
a線:1つの炭酸水素ナトリウムの結晶の端と端とを結ぶ直線が最長となる対端線
b線:a線と直交する直線が最長となる対端線 The average of the ratio of the following a line and the following b line (a line / b line) is 2 or more and 4 or less, and the bulk specific gravity is 1.05 g / mL or less. Sodium bicarbonate as a raw material for tableting as described.
Line a: the opposite end line where the straight line connecting the ends of one sodium bicarbonate crystal is the longest line b: The end line where the straight line orthogonal to the line a is the longest
a線:1つの炭酸水素ナトリウムの結晶の端と端とを結ぶ直線が最長となる対端線
b線:a線と直交する直線が最長となる対端線 The average of the ratio of the following a line and the following b line (a line / b line) is 2 or more and 4 or less, and uses sodium hydrogencarbonate whose bulk specific gravity is 1.05 g / mL or less as a raw material. The manufacturing method of the tableting tablet of Claim 1 characterized by the above-mentioned.
Line a: the opposite end line with the longest straight line connecting the ends of one sodium bicarbonate crystal b line: The end line with the longest straight line orthogonal to the line a
a線:1つの炭酸水素ナトリウムの結晶の端と端とを結ぶ直線が最長となる対端線
b線:a線と直交する直線が最長となる対端線 Sodium bicarbonate, sodium carbonate, organic acid, wherein the average of the ratio of the following a line and the following b line (a line / b line) is 2 or more and 4 or less and the bulk specific gravity is 1.05 g / mL or less, The tableting of Claim 1 obtained by tableting a cationized cellulose.
Line a: the opposite end line where the straight line connecting the ends of one sodium bicarbonate crystal is the longest line b: The end line where the straight line orthogonal to the line a is the longest
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018084436A JP7075809B2 (en) | 2018-04-25 | 2018-04-25 | Tablets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018084436A JP7075809B2 (en) | 2018-04-25 | 2018-04-25 | Tablets |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019189560A true JP2019189560A (en) | 2019-10-31 |
JP7075809B2 JP7075809B2 (en) | 2022-05-26 |
Family
ID=68389384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018084436A Active JP7075809B2 (en) | 2018-04-25 | 2018-04-25 | Tablets |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7075809B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7489561B1 (en) | 2024-03-15 | 2024-05-23 | 小林製薬株式会社 | Oral appliance cleaner for effervescent tablets |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05339005A (en) * | 1992-06-08 | 1993-12-21 | Tokuyama Soda Co Ltd | Method for producing sodium bicarbonate |
JPH07277948A (en) * | 1994-04-07 | 1995-10-24 | Kao Corp | Composition for coating and treating amine functional group-containing substance and composition containing the same |
JP2003104722A (en) * | 2001-09-28 | 2003-04-09 | Tosoh Corp | Caking resistant baking soda and method for producing the same |
JP2018008896A (en) * | 2016-07-13 | 2018-01-18 | アース製薬株式会社 | tablet |
-
2018
- 2018-04-25 JP JP2018084436A patent/JP7075809B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05339005A (en) * | 1992-06-08 | 1993-12-21 | Tokuyama Soda Co Ltd | Method for producing sodium bicarbonate |
JPH07277948A (en) * | 1994-04-07 | 1995-10-24 | Kao Corp | Composition for coating and treating amine functional group-containing substance and composition containing the same |
JP2003104722A (en) * | 2001-09-28 | 2003-04-09 | Tosoh Corp | Caking resistant baking soda and method for producing the same |
JP2018008896A (en) * | 2016-07-13 | 2018-01-18 | アース製薬株式会社 | tablet |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7489561B1 (en) | 2024-03-15 | 2024-05-23 | 小林製薬株式会社 | Oral appliance cleaner for effervescent tablets |
Also Published As
Publication number | Publication date |
---|---|
JP7075809B2 (en) | 2022-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7588890B2 (en) | Foaming skin care product | |
JP2016008181A (en) | Kit for skin external preparation | |
JP5692618B1 (en) | Skin preparation kit | |
JP7494421B2 (en) | Granule-blended effervescent tablet | |
JP6062279B2 (en) | Liquid detergent composition | |
JP7075809B2 (en) | Tablets | |
JP2014156538A (en) | Liquid detergent composition | |
JP6795922B2 (en) | tablet | |
JP6072186B1 (en) | Effervescent compression molding bath | |
JP2016094375A (en) | Liquid detergent composition for former container | |
JP6424356B2 (en) | Effervescent skin external preparation | |
JP2017165700A (en) | Effervescent tablet bath composition | |
JP6576194B2 (en) | Effervescent compression molding bath | |
JP2017066102A (en) | Effervescent bath agent of compression-molding type | |
JP6648230B2 (en) | Skin preparation kit | |
JP2017132702A (en) | Detergent composition | |
JP6851646B2 (en) | Kit for external preparations for skin | |
JP6616350B2 (en) | Foam compression molding | |
JP7558743B2 (en) | Skin cleansing composition | |
JP6617064B2 (en) | Bath agent composition | |
JP7540128B2 (en) | Bath additive composition | |
JP4348208B2 (en) | Compression mold bath agent | |
JP6628197B2 (en) | Skin preparation kit | |
JP7590073B2 (en) | Gel bath composition | |
JP6424355B2 (en) | Skin external preparation kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210121 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20211008 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211207 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220202 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220401 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220401 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220510 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220516 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7075809 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |